CTI BioPharma’s confirmatory trial of Pixuvri in lymphoma fails
The EMA required the PIX306 as a confirmatory trial for conditional approval, while CTI considered potentially using it to pursue FDA approval.
Article
The EMA required the PIX306 as a confirmatory trial for conditional approval, while CTI considered potentially using it to pursue FDA approval.